Report Overview

Global Preimplantation Genetic Testing market size was USD 653.52 million in 2023 and the market is projected to touch USD 1,420 million by 2031, at a CAGR of 9.0 % during the forecast period.

Global Preimplantation Genetic Testing Market report scope and segmentation.

Report Attribute

Details

Base Year

2023

Forecast Years

2024 – 2031

Estimated Market Value (2023)

USD 653.52 Million

Projected Market Value (2031)

USD 1,420 Million

Segments Covered

By Procedure Type, By Technology, By Product, By Application, By Type of Cycle, By End User & By Region.

Forecast Units

Value (USD Million or Billion)

Regions Covered

North America, Europe, Asia Pacific, Rest of the World (Latin America, and Middle East & Africa)

Countries Covered

U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, among others.

Global Preimplantation Genetic Testing Market dynamics

Many major factors drive global Preimplantation Genetic Testing market. Quick consumer preference as a result of increasingly hectic urban lifestyles is one of the most significant contributors.

Global Preimplantation Genetic Testing Market

  • Drivers:

Rising Consumer Demand for Convenience

Because the pace of life became accelerated and cities grew more urbanized there was also a requirement among consumers to have services that save time and bring instant satisfaction.

  • Restraints:

High Operational Costs

Infrastructure, especially for last-mile delivery solutions, demands a lot of money in Preimplantation Genetic Testing.

  • Opportunities:

Expansion into New Markets

The present-day Preimplantation Genetic Testing does very well in denser metropolises, however there are promising prospects for growth by enlarging into towns and villages.

  • Challenges:

Expansion into New Markets

The present-day Preimplantation Genetic Testing does very well in denser metropolises, however there are promising prospects for growth by enlarging into towns and villages.

  • Segment Overview

By Company Type, the Preimplantation Genetic Testing market is segmented into pureplay and non-pureplay companies.

Global Preimplantation Genetic Testing Market Overview by Region

Due to the extensive penetration of smartphones, robust e-commerce ecosystems and improved logistics networks,

Global Preimplantation Genetic Testing market competitive landscape

Key players include pureplay companies like Gopuff, Gorillas, and Getir, which focus exclusively on rapid delivery services.

Global Preimplantation Genetic Testing Market Recent Developments

  • December 2023, Flipkart acquired by Walmart, who also ventured into rapid-commerce delivery services and commenced operations within 20 Indian cities.

Global Preimplantation Genetic Testing report market segmentation

ATTRIBUTE

DETAILS

By Procedure Type

  • Preimplantation Genetic Screening
  • Preimplantation Genetic Diagnosis

By Technology

  • Next-Generation Sequencing
  • Polymerase Chain Reaction
  • Fluorescence In Situ Hybridization
  • Comparative Genomic Hybridization
  • Single-Nucleotide Polymorphism

By Product

  • Reagents and Consumables
  • Instruments
  • Software and Services

By Application

  • Aneuploidy
  • Structural Chromosomal Abnormalities
  • Single Gene Disorders
  • X-Linked Disorders
  • HLA Typing
  • Gender Identification

By Type of Cycle

  • Fresh non-Donor
  • Frozen non-Donor
  • Fresh Donor
  • Frozen Donor

By End User

  • Fertility Clinics
  • Hospitals
  • Diagnostic Laboratories
  • Other End Users

Customization Scope

  • Available upon request

Pricing

  • Available upon request

Frequently Asked Questions?

Ans - Global Preimplantation Genetic Testing market forecast period is 2024 – 2031

Ans - According to global Markstats research, the market is expected to grow at a CAGR of ~ 9.0% over the next eight years.

Ans - The expected market size for Global Preimplantation Genetic Testing is USD 1,420 million in 2031.

Ans - The possible segments in global Preimplantation Genetic Testing market are based on By Procedure Type, By Technology, By Product, By Application, By Type of Cycle, By End User & by region.

Ans - The major players in the market are Quest Diagnostics Incorporated, Natera, Inc., COOPER SURGICAL, INC., Genea Pty Limited., Invitae Corporation, Laboratory Corporation of America Holdings, Thermo Fisher Scientific Inc., Bioarray S.L., Illumina, Inc., Igenomix.